Inmunidad de las Mucosas y Alergia: de la Inmunopatología a la Terapia.
Universidad Autónoma de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (29)
2024
-
Evaluation of the transition from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel disease
Gastroenterologia y Hepatologia
-
Intensification with Intravenous Ustekinumab in Refractory Crohn’s Disease
Journal of Clinical Medicine, Vol. 13, Núm. 3
-
Selective granulocyte–monocyte apheresis during induction with vedolizumab in moderate–severe ulcerative colitis: Experience in a tertiary hospital
Gastroenterologia y Hepatologia, Vol. 47, Núm. 7, pp. 721-726
-
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA
Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 11, pp. 2280-2290
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Empirical rescue treatment of Helicobacter pylori infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on H. pylori management (Hp-EuReg)
Gut, Vol. 72, Núm. 6, pp. 1054-1072
-
Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress
Frontiers in immunology, Vol. 14, pp. 1185517
-
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease
Clinical Gastroenterology and Hepatology, Vol. 21, Núm. 3, pp. 771-788.e10
-
Influence of biologic therapy on cardiovascular risk factors in patients with inflammatory bowel disease
Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 109-115
-
Randomized clinical trial evaluating three low-volume preparations for colonoscopy in outpatients with Inflammatory Bowel Disease: the EII-PREP trial
Scandinavian Journal of Gastroenterology, Vol. 58, Núm. 6, pp. 656-663
-
Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease
Scientific Reports, Vol. 13, Núm. 1
2022
-
A first update on mapping the human genetic architecture of COVID-19
Nature
-
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)
Journal of Clinical Medicine
-
Metabolomics study of COVID-19 patients in four different clinical stages
Scientific reports, Vol. 12, Núm. 1, pp. 1650
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Whole-genome sequencing reveals host factors underlying critical COVID-19
Nature, Vol. 607, Núm. 7917, pp. 97-103
2021
-
Doppler Activity and Ultrasonographic Detection of Intra-Abdominal Fistulas Are Predictors of Surgery in Crohn's Disease
Digestive Diseases, Vol. 39, Núm. 3, pp. 204-210
-
Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study
Journal of Clinical Medicine, Vol. 10, Núm. 13
-
Lunasin Peptide is a Modulator of the Immune Response in the Human Gastrointestinal Tract
Molecular Nutrition and Food Research, Vol. 65, Núm. 12
-
Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates between Type and Mucosal Status in Patients with Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Vol. 27, Núm. 2, pp. 268-274